TGFB1 and cancer: In this regard, we reported that iNOS inhibitors diminish cancer cell proliferation and migration, CSC self-renewal and EMT by a targeting HIF1α and endoplasmic reticulum stress-transforming growth factor (TGFβ)-ATF4/ATF3 crosstalk [93].